Associated Papers
Mutant Phosphodiesterase 3A Protects From Hypertension-Induced Cardiac Damage.
Ercu M et al.
Circulation, 2022
Identification and functional study of genetic polymorphisms in cyclic nucleotide phosphodiesterase 3A (PDE3A).
Kim YR et al.
Annals of Human Genetics, 2021
Whole-exome sequencing identifies a de novo PDE3A variant causing autosomal dominant hypertension with brachydactyly type E syndrome: a case report.
Li X et al.
Bmc Medical Genetics, 2020
Hypertension and Brachydactyly Syndrome Associated With Vertebral Artery Malformation Caused by a PDE3A Missense Mutation.
Fan P et al.
American Journal of Hypertension, 2020
PDE3A gene screening improves diagnostics for patients with Bilginturan syndrome (hypertension and brachydactyly syndrome).
Renkema KY et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2018
Clinical effects of phosphodiesterase 3A mutations in inherited hypertension with brachydactyly.
Toka O et al.
Hypertension (dallas, Tex. : 1979), 2015
PDE3A mutations cause autosomal dominant hypertension with brachydactyly.
Maass PG et al.
Nature Genetics, 2015
Select a paper to view details